Literature DB >> 22972823

Production of KPC-2 alone does not always result in β-lactam MICs representing resistance in gram-negative pathogens.

Amanda L Roth1, Kenneth S Thomson, Philip D Lister, Nancy D Hanson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22972823      PMCID： PMC3502953          DOI： 10.1128/JCM.02194-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  8 in total

Review 1.  Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?

Authors:  David M Livermore; Jenny M Andrews; Peter M Hawkey; Pak-Leung Ho; Yoram Keness; Yohei Doi; David Paterson; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2012-03-29       Impact factor: 5.790

2.  Klebsiella pneumoniae isolate producing at least eight different beta-lactamases, including AmpC and KPC beta-lactamases.

Authors:  Ellen Smith Moland; Seong Geun Hong; Kenneth S Thomson; Davise H Larone; Nancy D Hanson
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

3.  bla(KPC) RNA expression correlates with two transcriptional start sites but not always with gene copy number in four genera of Gram-negative pathogens.

Authors:  Amanda L Roth; Philip M Kurpiel; Philip D Lister; Nancy D Hanson
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

4.  Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.

Authors:  H Yigit; A M Queenan; G J Anderson; A Domenech-Sanchez; J W Biddle; C D Steward; S Alberti; K Bush; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

5.  Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium.

Authors:  Simona Bratu; David Landman; Robin Haag; Rose Recco; Antonella Eramo; Maqsood Alam; John Quale
Journal:  Arch Intern Med       Date:  2005-06-27

6.  Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae.

Authors:  Brandon Kitchel; J Kamile Rasheed; Andrea Endimiani; Andrea M Hujer; Karen F Anderson; Robert A Bonomo; Jean B Patel
Journal:  Antimicrob Agents Chemother       Date:  2010-07-26       Impact factor: 5.191

7.  Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections.

Authors:  George L Daikos; Panayiotis Petrikkos; Mina Psichogiou; Chris Kosmidis; Evangelos Vryonis; Athanasios Skoutelis; Kleoniki Georgousi; Leonidas S Tzouvelekis; Panayotis T Tassios; Christina Bamia; George Petrikkos
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

8.  Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing.

Authors:  Fred C Tenover; Rajinder K Kalsi; Portia P Williams; Roberta B Carey; Sheila Stocker; David Lonsway; J Kamile Rasheed; James W Biddle; John E McGowan; Bruce Hanna
Journal:  Emerg Infect Dis       Date:  2006-08       Impact factor: 6.883
  8 in total
  3 in total

1.  Klebsiella pneumoniae Susceptibility to Carbapenem/Relebactam Combinations: Influence of Inoculum Density and Carbapenem-to-Inhibitor Concentration Ratio.

Authors:  Maria V Golikova; Kamilla N Alieva; Alla V Filimonova; Vladimir A Ageevets; Ofeliia S Sulian; Alisa A Avdeeva; Sergey V Sidorenko; Stephen H Zinner
Journal:  Biomedicines       Date:  2022-06-20

2.  Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae testing susceptible to cefepime by reference methods.

Authors:  Renata C Picão; Ronald N Jones; Rodrigo E Mendes; Mariana Castanheira
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

3.  Rapid optical determination of β-lactamase and antibiotic activity.

Authors:  Shazia Khan; Ulysses W Sallum; Xiang Zheng; Gerard J Nau; Tayyaba Hasan
Journal:  BMC Microbiol       Date:  2014-04-04       Impact factor: 3.605
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.